Browse Category

Stock Market News 28 January 2026

GE Vernova stock wobbles after earnings as GEV lifts 2026 forecast but flags Vineyard Wind hit

GE Vernova stock wobbles after earnings as GEV lifts 2026 forecast but flags Vineyard Wind hit

GE Vernova raised its 2026 revenue forecast to $44–$45 billion and reported a $150 billion backlog, sending shares up 0.4% to $695.58 Wednesday. The company warned its wind division could lose $250 million in revenue this year due to Vineyard Wind delays. Fourth-quarter orders jumped 65% to $22.2 billion. GE Vernova’s acquisition of Prolec GE is set to close February 2.
Netflix stock price slips as Senate sets Feb. 3 hearing on Warner deal, NFLX traders eye next catalysts

Netflix stock price slips as Senate sets Feb. 3 hearing on Warner deal, NFLX traders eye next catalysts

Netflix shares fell 0.8% to $84.92 as the Senate Judiciary antitrust subcommittee set a Feb. 3 hearing on Netflix’s $83 billion bid for Warner Bros Discovery assets. Senator Mike Lee warned the deal could sideline a competitor and pressed both firms on data safeguards. Warner Bros Discovery shares slipped 0.3%. The S&P 500 rose 0.3%, passing 7,000.
JPMorgan stock price holds near $300 as bank backs $1,000 ‘Trump Accounts’ match and traders eye the Fed

JPMorgan stock price holds near $300 as bank backs $1,000 ‘Trump Accounts’ match and traders eye the Fed

JPMorgan Chase shares were little changed Wednesday after the bank said it will match the U.S. government’s $1,000 “Trump Account” contributions for employees’ children. Bank of America will also match the benefit, according to an internal memo. Investors focused on the Federal Reserve’s rate decision, with bank stocks mostly flat. JPMorgan’s average loans rose 9% last quarter.
AT&T stock price jumps on 2026 outlook as fiber, spectrum deals come into focus

AT&T stock price jumps on 2026 outlook as fiber, spectrum deals come into focus

AT&T shares rose 4.7% to $24.08 in early New York trading Wednesday after the company raised profit and cash-flow forecasts through 2028. The carrier now targets over $18 billion in free cash flow by 2026 and annual capital spending of $23–$24 billion. Fourth-quarter revenue reached $33.5 billion, with adjusted EPS at $0.52. AT&T added 421,000 postpaid phone subscribers and 283,000 fiber net additions.
Bradesco stock price hovers near a 52-week high as Brazil rate decision nears, earnings next week

Bradesco stock price hovers near a 52-week high as Brazil rate decision nears, earnings next week

Banco Bradesco’s U.S.-listed shares edged up 0.1% Wednesday, hovering near a 52-week high as investors awaited Brazil’s central bank rate decision. January inflation hit 4.5%, matching the top of the target range, prompting traders to expect rates to hold steady. Bradesco will report fourth-quarter results Feb. 5. The bank renewed its agreement with payments firm Cielo.
UnitedHealth (UNH) stock rebounds after rout — what investors watch next on Medicare Advantage rates

UnitedHealth (UNH) stock rebounds after rout — what investors watch next on Medicare Advantage rates

UnitedHealth shares rose about 3% Wednesday after plunging nearly 20% Tuesday on a weak 2026 revenue forecast and a minimal 2027 Medicare Advantage payment update. The U.S. proposed a 0.09% hike in 2027 payments, far below market expectations. Investors await the final Medicare Advantage rate announcement in early April. Peers like Elevance Health also warned of ongoing cost pressures.
28 January 2026
Kenvue stock price dips as KVUE dividend set and Kimberly-Clark vote nears

Kenvue stock price dips as KVUE dividend set and Kimberly-Clark vote nears

Kenvue shares fell 0.3% to $17.44 Wednesday as investors awaited a Jan. 29 shareholder vote on Kimberly-Clark’s takeover bid. Kenvue declared a $0.2075 quarterly dividend, payable Feb. 25. The merger would give Kenvue holders 0.14625 Kimberly-Clark shares plus $3.50 cash per share. Kenvue and its board face shareholder lawsuits seeking more merger disclosures.
Pfizer stock dips after Xeljanz lands on Medicare price-talk list, with earnings looming

Pfizer stock dips after Xeljanz lands on Medicare price-talk list, with earnings looming

Pfizer shares fell 1.7% to $26.06 after CMS selected its arthritis drug Xeljanz for Medicare price negotiations, with new prices set for 2028. Xeljanz accounted for about $1.01 billion in Medicare spending in the latest period. Investors await Pfizer’s Feb. 3 quarterly results and a Feb. 28 CMS deadline for drugmakers to sign participation agreements.
Oracle stock price today: ORCL edges higher as TikTok outage and new cloud wins grab focus

Oracle stock price today: ORCL edges higher as TikTok outage and new cloud wins grab focus

Oracle shares rose 0.5% to $175.76 Wednesday morning after a 4.1% drop Tuesday. The company blamed a weekend TikTok outage on a weather-related power failure at a data center. California Governor Gavin Newsom said his office is reviewing TikTok’s moderation after the incident. Oracle also announced new cloud deals in Saudi Arabia and a planned cloud region in Kenya.
Intel stock price jumps nearly 10% as chip rally lifts INTC; CFO buy draws attention

Intel stock price jumps nearly 10% as chip rally lifts INTC; CFO buy draws attention

Intel shares jumped 9.6% to $48.16 by late morning Wednesday, rebounding from last week’s warning on AI chip supply and cautious outlook. The rally followed strong results from SK Hynix and ASML, lifting semiconductor stocks and pushing the S&P 500 above 7,000. CFO David Zinsner disclosed buying 5,882 shares at $42.50 each. Investors remain focused on Intel’s ability to meet demand and execute its foundry strategy.

Stock Market Today

Lucid stock jumps 14% as Dow tops 50,000 — what LCID investors watch next week

Lucid stock jumps 14% as Dow tops 50,000 — what LCID investors watch next week

7 February 2026
Lucid Group shares jumped 14% to $10.86 at Friday’s close, recovering from an 8% drop the previous day. The move followed a broad Wall Street rally that lifted high-volatility stocks. Lucid reported fourth-quarter deliveries of 5,345 vehicles and full-year deliveries of 15,841. Investors await Lucid’s Feb. 24 results for updates on cash and demand.
Go toTop